Stone Conroy

New Jersey

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Cases72
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
BiotechChemical BiotechMech Eng, Manuf
Elite Ratings
DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.
Experience
Grade
Trend
DCT
L5
A
PTAB
L5
A
CAFC
L5
A

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered
Case
Description
11/21/24
***Civil Case Terminated per Order at [23] . (sm) (Entered: 11/21/2024)
11/21/24
CLERK'S QUALITY CONTROL MESSAGE - Please note the Case Closing filed by the Clerk's office on 11/24/2024 was docketed in error. Please disregard. (sm) (Entered: 11/21/2024)
11/21/24
***Civil Case Terminated per Order at [23] . (sm) (Entered: 11/21/2024)
11/19/24
CLERK'S QUALITY CONTROL MESSAGE - Case Closed in Error, Please Disregard (ld, ) (Entered: 11/19/2024)
10/14/24
Exhibit to [1] Complaint,,, Civil Cover Sheet by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024)
10/14/24
Exhibit to [1] Complaint,,, Revised Exhibit 24 (AO 120 Form) by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024)
10/14/24
Corporate Disclosure Statement by Treace Medical Concepts, Inc.. (CONROY, REBEKAH) (Entered: 10/14/2024)
10/14/24
Exhibit to [1] Complaint,,, Unredacted Complaint (Filed Under Seal) by Treace Medical Concepts, Inc.. (CONROY, REBEKAH)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 10/14/2024)
10/14/24
COMPLAINT against All Defendants ( Filing and Admin fee $ 405 receipt number ANJDC-15734875) with JURY DEMAND, filed by Treace Medical Concepts, Inc.. (Attachments: # [1] Exhibit Ex. 1 to Compl., # [2] Exhibit Ex. 2 to Compl., # [3] Exhibit Ex. 3 to Compl., # [4] Exhibit Ex. 4 to Compl., # [5] Exhibit Ex. 5t o Compl., # [6] Exhibit Ex. 6 to Compl., # [7] Exhibit Ex. 7 to Compl., # [8] Exhibit Ex. 8 to Compl., # [9] Exhibit Ex. 9 to Compl., # [10] Exhibit Ex. 10 to Compl., # [11] Exhibit Ex. 11 to Compl., # [12] Exhibit Ex. 12 to Compl., # [13] Exhibit Ex. 13 to Compl., # [14] Exhibit Ex. 14 to Compl., # [15] Exhibit Ex. 15 to Compl., # [16] Exhibit Ex. 16 to Compl., # [17] Exhibit Ex. 17 to Compl., # [18] Exhibit Ex. 18 to Compl., # [19] Exhibit Ex. 19 to Compl., # [20] Exhibit Ex. 20 to Compl., # [21] Exhibit Ex. 21 to Compl., # [22] Exhibit Ex. 22 to Compl., # [23] Exhibit Ex. 23 to Compl., # [24] AO120 Report)(CONROY, REBEKAH) (Entered: 10/14/2024)
10/11/24
ANSWER to Complaint Plaintiffs' Answer to Alkem's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)